Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000088 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
22,500
Total Value
$766,789.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 7,500 | $14.50 | $108,750.00 | 105,494 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 1, 2026 | Sale | 5,775 | $87.55 | $505,601.25 | 99,719 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jul 1, 2026 | Sale | 1,725 | $88.37 | $152,438.25 | 97,994 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 352,357 | Direct | โ | View Details |